Tetanus Toxoid Articles
Burst of M&A activity in pharma during 2009 led by mega-deals from Pfizer/Wyeth and Merck & Co/S-P
4 February 2010
Childhood vaccination at record high, but access not yet equitable, say global health experts
21 October 2009
Sanofi starts Ph II C. Difficile vaccine study
23 February 2009
GAVI program money "paid for non-existent vaccinations"
12 January 2009
US FDA approves GSK's Boostrix
15 December 2008
UPDATE: PDCO has good news for Lux Bio and others
8 December 2008
US CDC satisfied with 25% HPV vacc coverage
20 October 2008
Australian study finds child vaccine effect
7 July 2008
Sanofi receives FDA license for Pentacel
30 June 2008
Akorn and CSL sign Aflurina distribution deal
3 March 2008
Dual therapy for PMTCT starts in SA
24 December 2007
IFFIm program celebrates first year with $912M donations to immunization projects worldwide
3 December 2007
Crucell's 3rd-qtr net loss narrows to $4.5M euros
3 December 2007
EC clears S-P's Organon acquistion
22 October 2007
China is world's biggest vacc maker, says SFDA
24 September 2007
Akorn launches tetanus diphtheria vacc in USA
17 September 2007
US CDC report: vacc levels at record highs
10 September 2007
Crucell's 2nd-qtr net loss narrows to 18.2 euros
3 September 2007
Immunization campaign launched by US CDC
13 August 2007
GSK's vaccine DTaP-IPV performs well at Ph III
14 May 2007
Akorn and MBL in vacc distribution accord
2 April 2007
Merck & Co suspends lobbying to make Gardasil compulsory ahead of report on its side effects
26 February 2007
Crucell's losses increase despite higher sales
19 February 2007
Pentacel gets FDA OK for pediatric use
5 February 2007
Cambridge Biostability and Panacea enter JV
11 December 2006
Crucell's Quinvaxem gets WHO prequalification
2 October 2006
Korean FDA OKs Crucell's Quinvaxem
3 April 2006
DTI grant for MNLpharma's sugar adjuvant technology
27 March 2006
Sanofi-Aventis sales slow on competition
6 February 2006
Sanofi Pasteur's Adacel available in USA
1 August 2005
FDA OKs Sanofi Pasteur's Adacel
20 June 2005
GSK's Boostrix approved by US FDA
9 May 2005
Stock Commentary - Europe
28 March 2005
Sanofi Pasteur's Adacel gets FDA panel backing
28 March 2005
GlaxoSmithKline files Boostrix BLA in USA
19 July 2004
Baltic states view joint Rx purchasing
5 April 2004
Israeli Rx import safety fears: funds and hospitals must take responsibility, says MoH
23 February 2004
GSK invsts 60M euros in Hungarian vaccine plant
13 October 2003
CDC votes to add GSK's Pediarix to vaccination schedule
10 March 2003
Aventis updates on near-term pipeline
10 February 2003
Aventis Pasteur launches Daptacel in USA
8 July 2002
US vaccine shortage addressed
24 June 2002
Aventis cancer vaccine trial now enrolling
18 February 2002
Shire gets Canadian approval for NeisVac-C.
21 January 2002
Strong 1st qtr for Rhein Biotech
9 May 2001
GAVI Africa initiative starts with GSK vaccine
6 April 2001
Update - FDA panel rejects pentavalent Infanrix
15 March 2001
FDA Oks new Tripedia DTaP vaccine
12 March 2001
US panel rejects GSK pentavalent vaccine
9 March 2001
GlaxoSmithKline starts life in 2001 on a strong financial footing
21 February 2001
Strong earnings growth for Glaxo Wellcome and SmithKline Beecham
1 November 2000
Hexavalent pediatric vaccines licensed in EU
26 October 2000
CPMP backs new pediatric vaccines from SB
5 July 2000
Vietnam plan to boost vaccines output
20 January 2000
Glaxo SmithKline, an R&D powerhouse and global number one
17 January 2000
BioChem sells NAV stake to Baxter
25 November 1999
BioChem sells NAV stake to Baxter
19 November 1999
Chiron terminates marketing deal with NAV
28 October 1999
Wyeth-Lederle withdraws RotaShield vaccine - updated story
21 October 1999
AHP close to settling $3 billion lawsuits?
17 September 1999
AHP weathers the storm with first Rapamune approval
17 September 1999
Stock Commentary New York
16 September 1999
WHO views thiomersal in vaccines
26 July 1999
SB seeks Infanrix HepB-IPV approval in the USA
19 July 1999
SB's Infanrix cleared for pre-school booster
6 May 1999
Aventis Pipeline Rich In Near-Term Prospects
10 December 1998
North American Vaccine Starts Sales of Certiva
30 November 1998
SmithKline Beecham Ground-Breaking In China
16 November 1998
Medeva Files For European Approval Of Hepagene
27 October 1998
Certiva DTaP Vaccine Launched In USA
16 October 1998
England/Wales 1997 Public Health Care Report
14 September 1998
NAV's Certiva Vaccine Approved In USA
6 August 1998
EU CPMP July Plenary Meeting
31 July 1998
Currency And Flu Factors Hold Back SB Results
22 July 1998
New Approvals Soon For DTaP-IPV Vaccine
25 June 1998
Certiva Nears Approval
11 May 1998
EMEA CPMP Plenary Meeting In February
10 March 1998
Pramipexole Approved In The European Union
5 March 1998
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
